Partners Capital Investment Group, LLP Argenx Se Transaction History
Partners Capital Investment Group, LLP
- $2.65 Billion
- Q1 2024
A detailed history of Partners Capital Investment Group, LLP transactions in Argenx Se stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 5,662 shares of ARGX stock, worth $2.47 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,662
Previous 11,597
51.18%
Holding current value
$2.47 Million
Previous $4.41 Million
49.47%
% of portfolio
0.08%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding ARGX
# of Institutions
356Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.4 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.39 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$966 Million0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.12MShares$922 Million0.51% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$813 Million0.13% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $24.1B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...